Literature DB >> 16469876

Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation.

Aline Mamo1, Jana Krosl, Evert Kroon, Janet Bijl, Alexander Thompson, Nadine Mayotte, Simon Girard, Richard Bisaillon, Nathalie Beslu, Mark Featherstone, Guy Sauvageau.   

Abstract

The Hoxa9 and Meis1 genes represent important oncogenic collaborators activated in a significant proportion of human leukemias with genetic alterations in the MLL gene. In this study, we show that the transforming property of Meis1 is modulated by 3 conserved domains, namely the Pbx interaction motif (PIM), the homeodomain, and the C-terminal region recently described to possess transactivating properties. Meis1 and Pbx1 interaction domain-swapping mutants are dysfunctional separately, but restore the full oncogenic activity of Meis1 when cotransduced in primary cells engineered to overexpress Hoxa9, thus implying a modular nature for PIM in Meis1-accelerated transformation. Moreover, we show that the transactivating domain of VP16 can restore, and even enhance, the oncogenic potential of the Meis1 mutant lacking the C-terminal 49 amino acids. In contrast to Meis1, the fusion VP16-Meis1 is spontaneously oncogenic, and all leukemias harbor genetic activation of endogenous Hoxa9 and/or Hoxa7, suggesting that Hoxa gene activation represents a key event required for the oncogenic activity of VP16-Meis1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469876     DOI: 10.1182/blood-2005-06-2244

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation.

Authors:  Mi Cai; Ellen M Langer; Jennifer G Gill; Ansuman T Satpathy; Jörn C Albring; Wumesh KC; Theresa L Murphy; Kenneth M Murphy
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

2.  Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.

Authors:  Maria-Paz Garcia-Cuellar; Julia Steger; Elisa Füller; Katrin Hetzner; Robert K Slany
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941

Review 3.  Therapeutic targeting of MLL.

Authors:  Michaela Liedtke; Michael L Cleary
Journal:  Blood       Date:  2009-03-16       Impact factor: 22.113

4.  Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis.

Authors:  Leila Dardaei; Elena Longobardi; Francesco Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-27       Impact factor: 11.205

5.  HOX proteins and leukemia.

Authors:  Kajal V Sitwala; Monisha N Dandekar; Jay L Hess
Journal:  Int J Clin Exp Pathol       Date:  2008-03-30

6.  The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.

Authors:  Yousaf A Mian; Nancy J Zeleznik-Le
Journal:  Leuk Res       Date:  2016-04-16       Impact factor: 3.156

7.  Chromosomal binding sites of the homeotic cofactor Homothorax.

Authors:  Lior Cohen; Adi Salzberg
Journal:  Mol Genet Genomics       Date:  2008-05-15       Impact factor: 3.291

8.  MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression.

Authors:  Magda A Meester-Smoor; Marjolein J F W Janssen; Gerard C Grosveld; Annelies de Klein; Wilfred F J van IJcken; Hannie Douben; Ellen C Zwarthoff
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

9.  Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model.

Authors:  Dimple Bansal; Claudia Scholl; Stefan Fröhling; Elizabeth McDowell; Benjamin H Lee; Konstanze Döhner; Patricia Ernst; Alan J Davidson; George Q Daley; Leonard I Zon; D Gary Gilliland; Brian J P Huntly
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-26       Impact factor: 11.205

10.  Transcriptional activation by MEIS1A in response to protein kinase A signaling requires the transducers of regulated CREB family of CREB co-activators.

Authors:  Siew-Lee Goh; Yvonne Looi; Hui Shen; Jun Fang; Caroline Bodner; Martin Houle; Andy Cheuk-Him Ng; Robert A Screaton; Mark Featherstone
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.